The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines. This report contains market size and forecasts of DNA Vaccines in global, including the following market information:
Global DNA Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global DNA Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five DNA Vaccines companies in 2022 (%)
The global DNA Vaccines market was valued at US$ 4776.4 million in 2022 and is projected to reach US$ 7856.9 million by 2029, at a CAGR of 7.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
We surveyed the DNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, by Type, 2022 (%)
Recombinant Protein Vaccine
Gene-Based Vaccine
Global DNA Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, by Application, 2022 (%)
Human
Animal
Global DNA Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DNA Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies DNA Vaccines revenues share in global market, 2022 (%)
Key companies DNA Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies DNA Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of DNA Vaccines, market overview.
Chapter 2: Global DNA Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global DNA Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 DNA Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global DNA Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global DNA Vaccines Overall Market Size
2.1 Global DNA Vaccines Market Size: 2022 VS 2029
2.2 Global DNA Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global DNA Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top DNA Vaccines Players in Global Market
3.2 Top Global DNA Vaccines Companies Ranked by Revenue
3.3 Global DNA Vaccines Revenue by Companies
3.4 Global DNA Vaccines Sales by Companies
3.5 Global DNA Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 DNA Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers DNA Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 DNA Vaccines Players in Global Market
3.8.1 List of Global Tier 1 DNA Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 DNA Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global DNA Vaccines Market Size Markets, 2022 & 2029
4.1.2 Recombinant Protein Vaccine
4.1.3 Gene-Based Vaccine
4.2 By Type - Global DNA Vaccines Revenue & Forecasts
4.2.1 By Type - Global DNA Vaccines Revenue, 2018-2023
4.2.2 By Type - Global DNA Vaccines Revenue, 2024-2029
4.2.3 By Type - Global DNA Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global DNA Vaccines Sales & Forecasts
4.3.1 By Type - Global DNA Vaccines Sales, 2018-2023
4.3.2 By Type - Global DNA Vaccines Sales, 2024-2029
4.3.3 By Type - Global DNA Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global DNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global DNA Vaccines Market Size, 2022 & 2029
5.1.2 Human
5.1.3 Animal
5.2 By Application - Global DNA Vaccines Revenue & Forecasts
5.2.1 By Application - Global DNA Vaccines Revenue, 2018-2023
5.2.2 By Application - Global DNA Vaccines Revenue, 2024-2029
5.2.3 By Application - Global DNA Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global DNA Vaccines Sales & Forecasts
5.3.1 By Application - Global DNA Vaccines Sales, 2018-2023
5.3.2 By Application - Global DNA Vaccines Sales, 2024-2029
5.3.3 By Application - Global DNA Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global DNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global DNA Vaccines Market Size, 2022 & 2029
6.2 By Region - Global DNA Vaccines Revenue & Forecasts
6.2.1 By Region - Global DNA Vaccines Revenue, 2018-2023
6.2.2 By Region - Global DNA Vaccines Revenue, 2024-2029
6.2.3 By Region - Global DNA Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global DNA Vaccines Sales & Forecasts
6.3.1 By Region - Global DNA Vaccines Sales, 2018-2023
6.3.2 By Region - Global DNA Vaccines Sales, 2024-2029
6.3.3 By Region - Global DNA Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America DNA Vaccines Revenue, 2018-2029
6.4.2 By Country - North America DNA Vaccines Sales, 2018-2029
6.4.3 US DNA Vaccines Market Size, 2018-2029
6.4.4 Canada DNA Vaccines Market Size, 2018-2029
6.4.5 Mexico DNA Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe DNA Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe DNA Vaccines Sales, 2018-2029
6.5.3 Germany DNA Vaccines Market Size, 2018-2029
6.5.4 France DNA Vaccines Market Size, 2018-2029
6.5.5 U.K. DNA Vaccines Market Size, 2018-2029
6.5.6 Italy DNA Vaccines Market Size, 2018-2029
6.5.7 Russia DNA Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries DNA Vaccines Market Size, 2018-2029
6.5.9 Benelux DNA Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia DNA Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia DNA Vaccines Sales, 2018-2029
6.6.3 China DNA Vaccines Market Size, 2018-2029
6.6.4 Japan DNA Vaccines Market Size, 2018-2029
6.6.5 South Korea DNA Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia DNA Vaccines Market Size, 2018-2029
6.6.7 India DNA Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America DNA Vaccines Revenue, 2018-2029
6.7.2 By Country - South America DNA Vaccines Sales, 2018-2029
6.7.3 Brazil DNA Vaccines Market Size, 2018-2029
6.7.4 Argentina DNA Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa DNA Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa DNA Vaccines Sales, 2018-2029
6.8.3 Turkey DNA Vaccines Market Size, 2018-2029
6.8.4 Israel DNA Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia DNA Vaccines Market Size, 2018-2029
6.8.6 UAE DNA Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck DNA Vaccines Major Product Offerings
7.1.4 Merck DNA Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK DNA Vaccines Major Product Offerings
7.2.4 GSK DNA Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi DNA Vaccines Major Product Offerings
7.3.4 Sanofi DNA Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Zoties
7.4.1 Zoties Company Summary
7.4.2 Zoties Business Overview
7.4.3 Zoties DNA Vaccines Major Product Offerings
7.4.4 Zoties DNA Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Zoties Key News & Latest Developments
7.5 Elanco
7.5.1 Elanco Company Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco DNA Vaccines Major Product Offerings
7.5.4 Elanco DNA Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Elanco Key News & Latest Developments
7.6 Boehringer-Ingelheim
7.6.1 Boehringer-Ingelheim Company Summary
7.6.2 Boehringer-Ingelheim Business Overview
7.6.3 Boehringer-Ingelheim DNA Vaccines Major Product Offerings
7.6.4 Boehringer-Ingelheim DNA Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer-Ingelheim Key News & Latest Developments
7.7 Indian Immunologicals
7.7.1 Indian Immunologicals Company Summary
7.7.2 Indian Immunologicals Business Overview
7.7.3 Indian Immunologicals DNA Vaccines Major Product Offerings
7.7.4 Indian Immunologicals DNA Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Indian Immunologicals Key News & Latest Developments
7.8 Plumbline Life Sciences
7.8.1 Plumbline Life Sciences Company Summary
7.8.2 Plumbline Life Sciences Business Overview
7.8.3 Plumbline Life Sciences DNA Vaccines Major Product Offerings
7.8.4 Plumbline Life Sciences DNA Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Plumbline Life Sciences Key News & Latest Developments
8 Global DNA Vaccines Production Capacity, Analysis
8.1 Global DNA Vaccines Production Capacity, 2018-2029
8.2 DNA Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global DNA Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 DNA Vaccines Supply Chain Analysis
10.1 DNA Vaccines Industry Value Chain
10.2 DNA Vaccines Upstream Market
10.3 DNA Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 DNA Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of DNA Vaccines in Global Market
Table 2. Top DNA Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global DNA Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global DNA Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global DNA Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global DNA Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers DNA Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers DNA Vaccines Product Type
Table 9. List of Global Tier 1 DNA Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DNA Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global DNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global DNA Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global DNA Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global DNA Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global DNA Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global DNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global DNA Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global DNA Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global DNA Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global DNA Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global DNA Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global DNA Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global DNA Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global DNA Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global DNA Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America DNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America DNA Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America DNA Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe DNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe DNA Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe DNA Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia DNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia DNA Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia DNA Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America DNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America DNA Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America DNA Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa DNA Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa DNA Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa DNA Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa DNA Vaccines Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck DNA Vaccines Product Offerings
Table 48. Merck DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK DNA Vaccines Product Offerings
Table 52. GSK DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi DNA Vaccines Product Offerings
Table 56. Sanofi DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Zoties Company Summary
Table 59. Zoties DNA Vaccines Product Offerings
Table 60. Zoties DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Zoties Key News & Latest Developments
Table 62. Elanco Company Summary
Table 63. Elanco DNA Vaccines Product Offerings
Table 64. Elanco DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Elanco Key News & Latest Developments
Table 66. Boehringer-Ingelheim Company Summary
Table 67. Boehringer-Ingelheim DNA Vaccines Product Offerings
Table 68. Boehringer-Ingelheim DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Boehringer-Ingelheim Key News & Latest Developments
Table 70. Indian Immunologicals Company Summary
Table 71. Indian Immunologicals DNA Vaccines Product Offerings
Table 72. Indian Immunologicals DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Indian Immunologicals Key News & Latest Developments
Table 74. Plumbline Life Sciences Company Summary
Table 75. Plumbline Life Sciences DNA Vaccines Product Offerings
Table 76. Plumbline Life Sciences DNA Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Plumbline Life Sciences Key News & Latest Developments
Table 78. DNA Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global DNA Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global DNA Vaccines Production by Region, 2018-2023 (K Units)
Table 81. Global DNA Vaccines Production by Region, 2024-2029 (K Units)
Table 82. DNA Vaccines Market Opportunities & Trends in Global Market
Table 83. DNA Vaccines Market Drivers in Global Market
Table 84. DNA Vaccines Market Restraints in Global Market
Table 85. DNA Vaccines Raw Materials
Table 86. DNA Vaccines Raw Materials Suppliers in Global Market
Table 87. Typical DNA Vaccines Downstream
Table 88. DNA Vaccines Downstream Clients in Global Market
Table 89. DNA Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. DNA Vaccines Segment by Type in 2022
Figure 2. DNA Vaccines Segment by Application in 2022
Figure 3. Global DNA Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global DNA Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global DNA Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. DNA Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by DNA Vaccines Revenue in 2022
Figure 9. By Type - Global DNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global DNA Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global DNA Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global DNA Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global DNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global DNA Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global DNA Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global DNA Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global DNA Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global DNA Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global DNA Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global DNA Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America DNA Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America DNA Vaccines Sales Market Share, 2018-2029
Figure 23. US DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe DNA Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe DNA Vaccines Sales Market Share, 2018-2029
Figure 28. Germany DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia DNA Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia DNA Vaccines Sales Market Share, 2018-2029
Figure 37. China DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America DNA Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America DNA Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa DNA Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa DNA Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE DNA Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global DNA Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production DNA Vaccines by Region, 2022 VS 2029
Figure 54. DNA Vaccines Industry Value Chain
Figure 55. Marketing Channels
